{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:30:14Z","timestamp":1788283814671,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It is well known that pregnancy-induced hypertension (PIH) contributes significantly to the mortality rates of both mothers and babies during pregnancy. The relationship between fatty acids (FAs) and PIH remains debatable, with the causality between the two yet to be definitively established.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two-sample univariable and multivariable Mendelian Randomization (MR) analyses were executed, based on pooled data from Genome-Wide Association Studies (GWAS), to investigate any causal impact of FAs on PIH. A suite of methods was employed to assess causality, including inverse variance weighting (IVW), weighted median, MR Egger, simple mode, and weighted mode. Subsequently, the data underwent a sensitivity analysis (using Leave-One-Out analysis), a heterogeneity test (with MR-PRESSO and Cochran\u2019s Q test), as well as a multiple validity test (using MR-Egger regression). In multivariable analyses, fatty acids were first grouped to observe the effect of individual FAs on PIH. Subsequently, factors such as diabetes, high blood pressure, and body mass index (BMI) were incorporated into a multivariable examination of the impact of each FA on PIH. During this process, the IVW, weighted median, MR-Lasso, and MR-Egger methods were employed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A systematic investigation was conducted into the causal impact of each FA on PIH. The findings indicated that Polyunsaturated Fatty Acids (PUFA), Omega3, the ratio of Omega6 to Omega3, and Docosahexaenoic Acid (DHA) have a causal relationship with PIH. Increases in PUFA, Omega3, and DHA could potentially reduce the risk of PIH, while an increase in the Omega6\/Omega3 ratio could heighten the risk. The impacts of other FAs (including Total Fatty Acids, Monounsaturated Fatty Acids (MUFA), Saturated Fatty Acids (SFA), and Omega 6) on PIH were not substantiated by the MR analysis. In the univariate leave-one-out analysis, rs174564 was identified in PUFA, Omega3, and DHA as having a significant role. The tests with MR-Egger and MR-PRESSO found that the results were not influenced by pleiotropy and heterogeneity. After adjusting for BMI, Diabetes Mellitus, and pre-existing hypertension in the multivariable analysis, the results mirrored those obtained univariable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The research implies that elevated levels of circulating PUFA, DHA, and Omega3 may serve as a protective mechanism against PIH, while higher Omega6\/Omega3 ratios could potentially increase the risk of PIH. These findings may inform clinical strategies for PIH prevention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01889-x","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:02:33Z","timestamp":1692180153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fatty acids and pregnancy-induced hypertension: a Mendelian randomization study"],"prefix":"10.1186","volume":"22","author":[{"given":"Zixuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"1889_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.emc.2019.01.008","volume":"37","author":"RG Wilkerson","year":"2019","unstructured":"Wilkerson RG, Ogunbodede AC. Hypertensive disorders of pregnancy. Emerg Med Clin North Am. 2019;37:301\u201316.","journal-title":"Emerg Med Clin North Am"},{"key":"1889_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5527\/wjn.v5.i5.418","volume":"5","author":"C Berry","year":"2016","unstructured":"Berry C, Atta MG. Hypertensive disorders in pregnancy. World J Nephrol. 2016;5:418\u201328.","journal-title":"World J Nephrol"},{"key":"1889_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ecl.2011.08.009","volume":"40","author":"CG Solomon","year":"2011","unstructured":"Solomon CG, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am. 2011;40:847\u201363.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1889_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00404-017-4341-9","volume":"295","author":"LMM Nardozza","year":"2017","unstructured":"Nardozza LMM, Caetano ACR, Zamarian ACP, Mazzola JB, Silva CP, Mar\u00e7al VMG, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295:1061\u201377.","journal-title":"Arch Gynecol Obstet"},{"key":"1889_CR5","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Pre-eclampsia","year":"2020","unstructured":"Gestational Hypertension and Pre-eclampsia. ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135:e237\u201360.","journal-title":"Obstet Gynecol"},{"key":"1889_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/jp.2011.194","volume":"32","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Feigenbaum SL, Crites Y, Escobar GJ, Yang J, Ferrara A, et al. Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome. J Perinatol. 2012;32:770\u20136.","journal-title":"J Perinatol"},{"key":"1889_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/ajcn\/69.2.293","volume":"69","author":"FV Velzing-Aarts","year":"1999","unstructured":"Velzing-Aarts FV, van der Klis FR, van der Dijs FP, Muskiet FA. Umbilical vessels of preeclamptic women have low contents of both n-3 and n-6 long-chain polyunsaturated fatty acids. Am J Clin Nutr. 1999;69:293\u20138.","journal-title":"Am J Clin Nutr"},{"key":"1889_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00001648-199505000-00007","volume":"6","author":"MA Williams","year":"1995","unstructured":"Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of pre-eclampsia. Epidemiology. 1995;6:232\u20137.","journal-title":"Epidemiology"},{"key":"1889_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1471-0528.2000.tb13235.x","volume":"107","author":"SF Olsen","year":"2000","unstructured":"Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG. 2000;107:382\u201395.","journal-title":"BJOG."},{"key":"1889_CR10","first-page":"469","volume":"101","author":"CM Smuts","year":"2003","unstructured":"Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol. 2003;101:469\u201379.","journal-title":"Obstet Gynecol"},{"key":"1889_CR11","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3945\/ajcn.111.033217","volume":"95","author":"SJ Zhou","year":"2012","unstructured":"Zhou SJ, Yelland L, McPhee AJ, Quinlivan J, Gibson RA, Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or pre-eclampsia. Am J Clin Nutr. 2012;95:1378\u201384.","journal-title":"Am J Clin Nutr"},{"key":"1889_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/md16050138","volume":"16","author":"M Phang","year":"2018","unstructured":"Phang M, Skilton MR. Marine omega-3 fatty acids, complications of pregnancy and maternal risk factors for offspring cardio-metabolic disease. Mar Drugs. 2018;16:138.","journal-title":"Mar Drugs"},{"key":"1889_CR13","first-page":"890","volume":"18","author":"Y Hao","year":"2022","unstructured":"Hao Y, Sun X, Wen N, Song D, Li H. Effects of n-3 polyunsaturated fatty acid supplementation on pregnancy outcomes: a systematic review and meta-analysis. Arch Med Sci. 2022;18:890\u20139.","journal-title":"Arch Med Sci"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tjog.2019.11.002","volume":"59","author":"F Bakouei","year":"2020","unstructured":"Bakouei F, Delavar MA, Mashayekh-Amiri S, Esmailzadeh S, Taheri Z. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or pre-eclampsia: a systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2020;59:8\u201315.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1889_CR15","volume-title":"Mendelian Randomization: Methods for Causal Inference Using Genetic Variants","author":"SB Thompson","year":"2021","unstructured":"Thompson SB, Simon G. Mendelian Randomization: Methods for Causal Inference Using Genetic Variants. 2nd ed. New York: Chapman and Hall\/CRC; 2021.","edition":"2"},{"key":"1889_CR16","doi-asserted-by":"publisher","first-page":"119.e15","DOI":"10.1016\/j.neurobiolaging.2020.10.022","volume":"100","author":"Z Zhuang","year":"2021","unstructured":"Zhuang Z, Gao M, Yang R, Liu Z, Cao W, Huang T. Causal relationships between gut metabolites and Alzheimer\u2019s disease: a bidirectional Mendelian randomization study. Neurobiol Aging. 2021;100:119.e15-119.e18.","journal-title":"Neurobiol Aging"},{"key":"1889_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"1889_CR18","doi-asserted-by":"publisher","first-page":"720876","DOI":"10.3389\/fimmu.2021.720876","volume":"12","author":"S Si","year":"2021","unstructured":"Si S, Li J, Tewara MA, Xue F. genetically determined chronic low-grade inflammation and hundreds of health outcomes in the UK Biobank and the FinnGen population: a phenome-wide mendelian randomization study. Front Immunol. 2021;12:720876.","journal-title":"Front Immunol"},{"key":"1889_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"1889_CR20","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35:4851\u20133.","journal-title":"Bioinformatics"},{"key":"1889_CR21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/cam4.695","volume":"5","author":"CJ Bull","year":"2016","unstructured":"Bull CJ, Bonilla C, Holly JMP, Perks CM, Davies N, Haycock P, et al. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Med. 2016;5:1125\u201336.","journal-title":"Cancer Med"},{"key":"1889_CR22","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jacc.2022.03.335","volume":"79","author":"JJ Stuart","year":"2022","unstructured":"Stuart JJ, Tanz LJ, Rimm EB, Spiegelman D, Missmer SA, Mukamal KJ, et al. Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy. J Am Coll Cardiol. 2022;79:1901\u201313.","journal-title":"J Am Coll Cardiol"},{"key":"1889_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"1889_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/bmj.318.7183.600a","volume":"318","author":"R Bender","year":"1999","unstructured":"Bender R, Lange S. Multiple test procedures other than Bonferroni\u2019s deserve wider use. BMJ. 1999;318:600\u2013600.","journal-title":"BMJ"},{"key":"1889_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0006-3223(98)00043-2","volume":"44","author":"F Curtin","year":"1998","unstructured":"Curtin F, Schulz P. Multiple correlations and bonferroni\u2019s correction. Biol Psychiat. 1998;44:775\u20137.","journal-title":"Biol Psychiat"},{"key":"1889_CR26","first-page":"361","volume-title":"Advances in Pharmacology","author":"JS Possomato-Vieira","year":"2016","unstructured":"Possomato-Vieira JS, Khalil RA. Chapter Eleven - Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Pre-eclampsia. In: Khalil RA, editor. Advances in Pharmacology. Academic Press; 2016. p. 361\u2013431."},{"key":"1889_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s13224-017-0988-1","volume":"68","author":"K Sharma","year":"2018","unstructured":"Sharma K, Singh R, Kumar M, Gupta U, Rohil V, Bhattacharjee J. First-trimester inflammatory markers for risk evaluation of pregnancy hypertension. J Obstet Gynecol India. 2018;68:27\u201332.","journal-title":"J Obstet Gynecol India"},{"key":"1889_CR28","doi-asserted-by":"publisher","first-page":"5581570","DOI":"10.1155\/2021\/5581570","volume":"2021","author":"WN Phoswa","year":"2021","unstructured":"Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (Pre-eclampsia, Gestational Hypertension) and metabolic disorder of pregnancy (Gestational Diabetes Mellitus). Oxid Med Cell Longev. 2021;2021:5581570.","journal-title":"Oxid Med Cell Longev"},{"key":"1889_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrneph.2010.156","volume":"7","author":"H Shapiro","year":"2011","unstructured":"Shapiro H, Theilla M, Attal-Singer J, Singer P. Effects of polyunsaturated fatty acid consumption in diabetic nephropathy. Nat Rev Nephrol. 2011;7:110\u201321.","journal-title":"Nat Rev Nephrol"},{"key":"1889_CR30","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/phar.2615","volume":"41","author":"AR Barry","year":"2021","unstructured":"Barry AR, Dixon DL. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease. Pharmacotherapy. 2021;41:1056\u201365.","journal-title":"Pharmacotherapy"},{"key":"1889_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.fitote.2017.09.015","volume":"123","author":"TA Mori","year":"2017","unstructured":"Mori TA. Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease. Fitoterapia. 2017;123:51\u20138.","journal-title":"Fitoterapia"},{"key":"1889_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11936-016-0487-1","volume":"18","author":"KJ Bowen","year":"2016","unstructured":"Bowen KJ, Harris WS, Kris-Etherton PM. Omega-3 fatty acids and cardiovascular disease: are there benefits? Curr Treat Options Cardiovasc Med. 2016;18:69.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"1889_CR33","first-page":"1","volume":"133","author":"ACOG Practice Bulletin No","year":"2019","unstructured":"ACOG Practice Bulletin No. 202: Gestational hypertension and pre-eclampsia. Obstet Gynecol. 2019;133:1.","journal-title":"Obstet Gynecol"},{"key":"1889_CR34","doi-asserted-by":"publisher","first-page":"14380","DOI":"10.3390\/ijms232214380","volume":"23","author":"C Astore","year":"2022","unstructured":"Astore C, Nagpal S, Gibson G. Mendelian randomization indicates a causal role for omega-3 fatty acids in inflammatory bowel disease. Int J Mol Sci. 2022;23:14380.","journal-title":"Int J Mol Sci"},{"key":"1889_CR35","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s10067-022-06052-y","volume":"41","author":"G Zhu","year":"2022","unstructured":"Zhu G, Zhou S, Xu Y, Gao R, Li H, Zhai B, et al. Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis. Clin Rheumatol. 2022;41:1305\u201312.","journal-title":"Clin Rheumatol"},{"key":"1889_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/nutrit\/nuz086","volume":"78","author":"MC Conway","year":"2020","unstructured":"Conway MC, McSorley EM, Mulhern MS, Strain JJ, Van Wijngaarden E, Yeates AJ. Influence of fatty acid desaturase (FADS) genotype on maternal and child polyunsaturated fatty acids (PUFA) status and child health outcomes: a systematic review. Nutr Rev. 2020;78:627\u201346.","journal-title":"Nutr Rev"},{"key":"1889_CR37","doi-asserted-by":"publisher","first-page":"808054","DOI":"10.3389\/fnut.2021.808054","volume":"8","author":"FH Chilton","year":"2021","unstructured":"Chilton FH, Manichaikul A, Yang C, O\u2019Connor TD, Johnstone LM, Blomquist S, et al. Interpreting clinical trials with omega-3 supplements in the context of ancestry and FADS genetic variation. Front Nutr. 2021;8:808054.","journal-title":"Front Nutr"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01889-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:40:09Z","timestamp":1700257209000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01889-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01889-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All datasets in the present study were downloaded from public databases (), including the UK Biobank and the FinnGen database. These public databases allowed researchers to download and analyze public datasets for scientific purposes; thus, ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}